Gastrointestinal mucosal barrier function and diseases

被引:196
作者
Oshima, Tadayuki [1 ]
Miwa, Hiroto [1 ]
机构
[1] Hyogo Coll Med, Div Gastroenterol, Dept Internal Med, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan
关键词
Claudin; Permeability; Tight junction; Esophagitis; Cancer; Irritable bowel syndrome; IRRITABLE-BOWEL-SYNDROME; TIGHT-JUNCTION PROTEINS; ADHESION MOLECULE-A; DILATED INTERCELLULAR SPACES; NONEROSIVE REFLUX DISEASE; E-CADHERIN EXPRESSION; INTESTINAL PERMEABILITY; CLAUDIN EXPRESSION; DOWN-REGULATION; GASTRIC-CANCER;
D O I
10.1007/s00535-016-1207-z
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The gastrointestinal mucosal barrier plays an essential role in the separation of the inside of the body from the outside environment. Tight junctions (TJs) are the most important component for construction of a constitutive barrier of epithelial cells, and they regulate the permeability of the barrier by tightly sealing the cell-cell junctions. TJ proteins are represented by claudins, occludin, junctional adhesion molecules, and scaffold protein zonula occludens. Among these TJ proteins, claudins are the major components of TJs and are responsible for the barrier and the polarity of the epithelial cells. Gastrointestinal diseases including reflux esophagitis, inflammatory bowel disease, functional gastrointestinal disorders, and cancers may be regulated by these molecules, and disruption of their functions leads to chronic inflammatory conditions and chronic or progressive disease. Therefore, regulation of the barrier function of epithelial cells by regulating the expression and localization of TJ proteins is a potential new target for the treatment of these diseases. Treatment strategies for these diseases might thus be largely altered if symptom generation and/or immune dysfunction could be regulated through improvement of mucosal barrier function. Since TJ proteins may also modify tumor infiltration and metastasis, other important goals include finding a good TJ biomarker of cancer progression and patient prognosis, and developing TJ protein-targeted therapies that can modify patient prognosis. This review summarizes current understanding of gastrointestinal barrier function, TJ protein expression, and the mechanisms underlying epithelial barrier dysregulation in gastrointestinal diseases.
引用
收藏
页码:768 / 778
页数:11
相关论文
共 113 条
  • [1] Alterations in junctional proteins, inflammatory mediators and extracellular matrix molecules in eosinophilic esophagitis
    Abdulnour-Nakhoul, Solange M.
    Al-Tawil, Youhanna
    Gyftopoulos, Alex A.
    Brown, Karen L.
    Hansen, Molly
    Butcher, Kathy F.
    Eidelwein, Alexandra P.
    Noel, Robert A.
    Rabon, Edd
    Posta, Allison
    Nakhoul, Nazih L.
    [J]. CLINICAL IMMUNOLOGY, 2013, 148 (02) : 265 - 278
  • [2] Glutamine for induction of remission in Crohn's disease
    Akobeng, Anthony K.
    Elawad, Mamoun
    Gordon, Morris
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (02):
  • [3] Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study
    Arul, GS
    Moorghen, M
    Myerscough, N
    Alderson, DA
    Spicer, RD
    Corfield, AP
    [J]. GUT, 2000, 47 (06) : 753 - 761
  • [4] Altered localization and expression of tight-junction proteins in a rat model with chronic acid reflux esophagitis
    Asaoka, D
    Miwa, H
    Hirai, S
    Ohkawa, A
    Kurosawa, A
    Kawabe, M
    Hojo, M
    Nagahara, A
    Minoo, T
    Ohkura, R
    Ohkusa, T
    Sato, N
    [J]. JOURNAL OF GASTROENTEROLOGY, 2005, 40 (08) : 781 - 790
  • [5] Mucosal Impedance Discriminates GERD From Non-GERD Conditions
    Ates, Fehmi
    Yuksel, Elif Saritas
    Higginbotham, Tina
    Slaughter, James C.
    Mabary, Jerry
    Kavitt, Robert T.
    Garrett, C. Gaelyn
    Francis, David
    Vaezi, Michael F.
    [J]. GASTROENTEROLOGY, 2015, 148 (02) : 334 - 343
  • [6] BLAME IT ON THE ANTIBODIES
    Baker, Monya
    [J]. NATURE, 2015, 521 (7552) : 274 - 276
  • [7] The Expression and the Cellular Distribution of the Tight Junction Proteins Are Altered in Irritable Bowel Syndrome Patients With Differences According to the Disease Subtype
    Bertiaux-Vandaele, Nathalie
    Youmba, Stephanie Beutheu
    Belmonte, Liliana
    Lecleire, Stephane
    Antonietti, Michel
    Gourcerol, Guillaume
    Leroi, Anne-Marie
    Dechelotte, Pierre
    Menard, Jean-Francois
    Ducrotte, Philippe
    Coeffier, Moise
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (12) : 2165 - 2173
  • [8] Glutamine Restores Tight Junction Protein Claudin-1 Expression in Colonic Mucosa of Patients With Diarrhea-Predominant Irritable Bowel Syndrome
    Bertrand, Julien
    Ghouzali, Ibtissem
    Guerin, Charlene
    Bole-Feysot, Christine
    Gouteux, Melodie
    Dechelotte, Pierre
    Ducrotte, Philippe
    Coeffier, Moise
    [J]. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2016, 40 (08) : 1170 - 1176
  • [9] Intestinal permeability - a new target for disease prevention and therapy
    Bischoff, Stephan C.
    Barbara, Giovanni
    Buurman, Wim
    Ockhuizen, Theo
    Schulzke, Joerg-Dieter
    Serino, Matteo
    Tilg, Herbert
    Watson, Alastair
    Wells, Jerry M.
    [J]. BMC GASTROENTEROLOGY, 2014, 14
  • [10] Esophageal barrier function and tight junction expression in healthy subjects and patients with gastroesophageal reflux disease: functionality of esophageal mucosa exposed to bile salt and trypsin in vitro
    Bjorkman, Eleonora Victoria Charlotta
    Edebo, Anders
    Oltean, Mihai
    Casselbrant, Anna
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2013, 48 (10) : 1118 - 1126